Mumbai, Aug 14 (UNI) Pharma Major, Cadila Healthcare said that Company has entered into an agreement to invest in the equity shares of Windlass Healthcare Private Limited (WHPL) for acquiring 51 per cent

share capital of Windlas.

Commenting on the development, Managing Director of Cadila Healthcare, Sharvil Patel said, 'We see this as an opportunity to ramp up our operations and increase our product offerings. Windlas Healthcare's cost-efficient manufacturing infrastructure and technical competence to develop a competitive product pipeline will

be a great asset for us.'

Windlas Healthcare has a robust manufacturing infrastructure with a USFDA inspected oral solids manufacturing facility. WHPL also has a dedicated R&D facility for formulations development and has

developed four First-to-File ANDAs in the last two years. The strategic deal allows Cadila Healthcare to expand its existing manufacturing base.

UNI JS NV SB 1302